Opening book details…
About this Immunology and Microbiology article
Antitumor Potency of an Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, Lisocabtagene Maraleucel in Combination With Ibrutinib or Acalabrutinib by Qin, Jim S.; Johnstone, Timothy G.; Baturevych, Alex; Hause, Ronald J.; Ragan, Seamus P.; Clouser, Christopher R.; Jones, Jon C.; Ponce, Rafael; Krejsa, Cecile M.; Salmon, Ruth A.; Ports, Michael O. is a Immunology and Microbiology article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Immunology and Microbiology.
- Author
- Qin, Jim S.; Johnstone, Timothy G.; Baturevych, Alex; Hause, Ronald J.; Ragan, Seamus P.; Clouser, Christopher R.; Jones, Jon C.; Ponce, Rafael; Krejsa, Cecile M.; Salmon, Ruth A.; Ports, Michael O.
- Publisher
- Lippincott Williams and Wilkins; Ovid Technologies (Wolters Kluwer) - Lippincott Williams & Wilkins; Lippincott Williams & Wilkins Ltd.; Ovid Technologies (Wolters Kluwer Health) (ISSN 1053-8550)
- Published
- 2020
- Field
- Immunology and Microbiology (Life Sciences)